Search Within

Gynecologic Medicine Service

Formats
  1. Journal Article (1104)
  2. Meeting Abstract (902)
  3. Review (55)
  4. Book Section (46)
  5. Editorial (36)
  6. Guidelines (22)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Solid Tumor Oncology Division (2180)
  2. Department of Medicine (2174)
  3. Gynecology Disease Management Team (1877)
  4. GDMT, Medicine (1859)
  5. Surgery (603)
  6. GDMT, Surgery (479)

More Groups

People
  1. Carol Aghajanian (615)
  2. Nadeem Abu-Rustum (292)
  3. Martee Hensley (290)
  4. Roisin O'Cearbhaill (273)
  5. Vicky Makker (269)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (75)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (458)
  2. Gynecologic Oncology (420)
  3. International Journal of Gynecological Cancer (161)
  4. Annals of Oncology (117)
  5. Clinical Cancer Research (71)
  6. Cancer Research (55)

More Publications

Publishers
  1. American Society of Clinical Oncology (498)
  2. Elsevier B.V. (446)
  3. Lippincott Williams & Wilkins (188)
  4. American Association for Cancer Research (173)
  5. Oxford University Press (144)
  6. Elsevier Inc. (128)

More Publishers

Results (2180)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Exploratory analysis of percentage of genomic loss of heterozygosity (LOH) in patients with platinum-sensitive recurrent ovarian carcinoma (rOC) in ARIEL3
    Meeting Abstract

    Oaknin, A.; Ledermann, J. A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Dean, A. P.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase I study of concomitant galinpepimut-s (GPS) in combination with nivolumab (nivo) in patients (pts) with WT1+ ovarian cancer (OC) in second or third remission
    Meeting Abstract

    O'Cearbhaill, R. E.; Gnjatic, S.; Aghajanian, C.; Iasonos, A.; Konner, J. A.; Losada, N.; Sarasohn, D.; Rasalan, T.; Tew, W. P.; Zamarin, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Baseline demographics and disparities in cancer registration trials: An analysis of US Food and Drug Administration approved drugs in 2015 and 2016
    Meeting Abstract

    Maniar, R.; Green, A.; Bach, P.; Mailankody, S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab in patients with renal cell carcinoma: Updated results
    Meeting Abstract

    Lee, C. H.; Makker, V.; Rasco, D. W.; Taylor, M. H.; Stepan, D. E.; Shumaker, R. C.; Schmidt, E. V.; Guo, M.; Dutcus, C. E.; Motzer, R. J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase 1 study of MSC-1, a humanized anti-LIF monoclonal antibody, in patients with advanced solid tumors
    Meeting Abstract

    Hyman, D. M.; Brana, I.; Spreafico, A.; Schram, A. M.; Pandya, N. B.; Hoffman, K.; Hallet, R.; Giblin, P.; Anido, J.; Ruano, I. H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase I/II study of LAG525 ± spartalizumab (PDR001) in patients (pts) with advanced malignancies
    Meeting Abstract

    Hong, D. S.; Schoffski, P.; Calvo, A.; Sarantopoulos, J.; De Olza, M. O.; Carvajal, R. D.; Prawira, A.; Kyi, C.; Esaki, T.; Akerley, W. L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for uterus-limited, high-grade leiomyosarcoma: A phase III GOG study
    Meeting Abstract

    Hensley, M. L.; Enserro, D.; Hatcher, H.; Ottevanger, P. B.; Krarup-Hansen, A.; Blay, J. Y.; Fisher, C.; Moxley, K. M.; Lele, S. B.; Lea, J. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The clinical utility of prospective molecular characterization in advanced cervical and vulvovaginal cancer
    Meeting Abstract

    Friedman, C. F.; Donoghue, M.; Vivek, M.; Aghajanian, C.; Abu-Rustum, N.; Cadoo, K. A.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Kyi, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • DNA damage repair (DDR) germline mutations in patients (Pts) with urothelial carcinoma (UC)
    Meeting Abstract

    Carlo, M. I.; Vijai, J.; Mandelker, D.; Kemel, Y.; Regazzi, A. M.; Zhang, L.; Stadler, Z. K.; Walsh, M. F.; Cadoo, K. A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save